|
News (reporter: Liu Mengqi; Xu Feng). The reporter gained a piece of news from the Economic and Technological Development Zone that forty enterprises above designated size were added in the development zone within one year; the target of “net increase” of industrial enterprises above designated size was realized, which effectively stimulated the new development vitality of the real economy.
In recent years, the development zone has deeply excavated the potential of “increasing size”, and promoted the whole-chain service pattern of “deep potential excavation, dynamic tracking and accurate service” for industries which might reach the designated size and industrial enterprises below the designated size. Moreover, a batch of small and micro enterprises with good growth, rapid development, high technological content and strong innovation ability have been selected into the cultivation library of industrial enterprises above the designated size for major support. Until now, the development zone has gained a cultivation library of 100 enterprises, and gathered 321 industrial enterprises above the designated size. It tries to strive for 350 enterprises.
On that day, the reporter visited Hangzhou Rejoin Mastin Medical Equipment Co., Ltd. in the development zone, and the workers were working orderly in the workshop. After the company reached the designated size, the product sales volume broke through 67 million Yuan. In the first quarter of this year only, the sales volume approached 25 million Yuan, and is expected to reach 180 million Yuan in the whole year.
According to information, “Rejoin Mastin” is an enterprise engaging in research, development and production of medical machinery in the field of sports medicine, and its “star product” meniscus stapler broke the monopoly of the imported brand for this produce for 8 years as the exclusive product of the same type made in China. At present, this product covers all Chinese provinces, autonomous regions and municipalities except Taiwan and Xinjiang. Reaching the CE certificate standard, the product is sold to regions like Europe, Africa and Latin America, and becomes the “knock-out product” of Chinese sports medicine brand.
The company’s Board Secretary Feng Qi said, “As the representative of enterprises above the designated size, the development of “Rejoin Mastin” has entered the rapid-growth period, which has not only affirmed our behavior of sticking to independent brand research and development, but also raised higher requirements for our future development. In the future, we will focus on research, development and market development, and further increase the depth and width of product research and development.”